Digital Strategies in the Pharmaceutical Industry [Hardcover]

Leonard Lerer (Author), Mike Piper (Author)

Book Description

Publication Date: May 2, 2003

This book is a comprehensive review of the current state of digital innovation, Internet activity, and e-business in the life sciences arena and a practical guide for managers planning, developing, and implementing e-strategies in the pharmaceutical industry. The authors provide numerous examples of innovative, best practice and lay the strategic foundation for using e-business across the pharmaceutical value chain from drug discovery to physician promotion to direct-to-consumer marketing.

Editorial Reviews

About the Author

Leonard Lerer is currently an adviser to the pharmaceutical and biotechnology industry focusing on investment and analytics.

Mike Piper is a research analyst focusing on the pharmaceuticals and biotechnology sectors.

Product Details

• Hardcover: 200 pages
• Publisher: Palgrave Macmillan (May 2, 2003)
• Language: English
• ISBN-10: 1403903794
• ISBN-13: 978-1403903792
• Product Dimensions: 9.7 x 6.3 x 0.8 inches
• Shipping Weight: 1.2 pounds (View shipping rates and policies)
• Average Customer Review: 4.3 out of 5 stars  See all reviews (3 customer reviews)
• Amazon Best Sellers Rank: #1,368,516 in Books (See Top 100 in Books)

More About the Author

Discover books, learn about writers, read author blogs, and more.

Customer Reviews

Most Helpful Customer Reviews

1 of 1 people found the following review helpful:

3.0 out of 5 stars Decent, but Dated, August 8, 2009

By 

Joseph Fylypowycz "Consulting Lifer" (Philadelphia, PA) - See all my reviews
(REAL NAME)   

This review is from: Digital Strategies in the Pharmaceutical Industry (Hardcover)

Although some of the information contained in the book is relevant to the industry today, I always find it a little frustrating when a book from 6 years ago can be given some new cover art and presented as up to date.

Bottom line here is that the editor has not even felt it necessary to update relevant statistics that are quoted and only infrequently has added new content. If you are happy with information that was new 6 years ago, then this is still a good source of information.

1 of 1 people found the following review helpful:

5.0 out of 5 stars The Best book about the Industry, December 22, 2004

By 

Alejandro Garcia De La V "Alejandro Garcia" (USA and Mexico) - See all my reviews
(REAL NAME)   

This review is from: Digital Strategies in the Pharmaceutical Industry (Hardcover)

I work in one of the biggest pharmaceutical companies, in the marketing-e-business department. I can assure you that this is by far the best book about the pharmaceutical industry. It is not only about Information systems related areas, it covers too marketing, R&D, Human resources, finance, sales, etc. It has a great vision about the industry; I can tell you that book is "the bible" in our corporate headquarters. If you want to increase your knowledge about marketing in the industry, this is the book for you. The author is Editor of a leading journal, the "International Journal of Medical Marketing", teacher at INSEAD and a consultant for Pfizer, Merck, GSK, Aventis, Novartis and Roche, so he includes in this book information from top sources.

1 of 1 people found the following review helpful:

5.0 out of 5 stars All you want to know about digital strategies in "Pharma", August 5, 2003

By 

Ray Harald Puth (Saarbrücken) - See all my reviews
(REAL NAME)   

This review is from: Digital Strategies in the Pharmaceutical Industry (Hardcover)

A "digital strategy in the pharmaceutical industry" is not at all the addition of an "e-business"-unit or -department to an existing organisational structure. It's much more about how sales & marketing, research & development and other functions can increase efficiency and effectiveness by making use of digital technology. At the same time, the technological challenges suggest to develop an integrated strategic approach instead of focusing on sales & marketing or other functions alone or in isolation. This book tells you why. And - to a certain degree - also how. Since few readers will be competent in all covered business functions, it is very helpful that the authors provide definitions and basic background information for all of them, before they outline the impact of digital technology and strategy. Finally, a great amount of examples from real business cases illustrate the theoretical framework.
To me this book is a very successful approach to present an integrated view of different business functions and IT in the pharmaceutical industry.